A rapidly shifting medical landscape is facilitating progressive enhancements in the diagnosis and treatment of gastroesophageal junction adenocarcinoma. Particularly prominent are advancements in personalized medicine, which are optimizing solutions based on individual genetic profiles. Combinations of chemotherapy, radiation therapy, and surgery are increasingly being supplemented and even supplanted by targeted...
Discover more insights